CULVER CITY, Calif.--(BUSINESS WIRE)--May 23, 2017--
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based,
personalized healthcare company, today announced the appointment of
Ronald A. Louks as its Chief Operating Officer.
“Ron brings senior level leadership and excellent experience, gained at
some of the most highly regarded and well recognized companies in the
world, including Blackberry, HTC and Sony Ericsson,” said Patrick
Soon-Shiong, M.D., Chief Executive Officer and Chairman of NantHealth.
“His credentials and experience as an operations leader who can drive
innovation in global organizations speak for themselves. Ron will
oversee the company’s global operations; he has expertise in launching
new products globally, mergers and acquisitions, supply chain, sales
operations, marketing, manufacturing, e-commerce, retail, quality
control, information technology and growing early stage businesses. We
welcome Ron and he will play an instrumental role to build and execute
our global strategy and drive the company’s growing market share and
Prior to joining NantHealth, Louks served as President of Devices &
Emerging Solutions at BlackBerry Limited. Earlier, Louks served as Chief
Executive Officer of the OpenNMS Group, the world’s largest open-source
network management company. Before that, he was Chief Strategy Officer
for HTC Corporation, where he was also responsible for driving new
strategic initiatives and all new technologies including M&A
responsibilities. Previous to this, he held a number of senior
leadership positions at Sony Ericsson, most recently serving as its
Chief Technology Officer. He has driven innovation and launched new
products, commercializing them, and shipped more than 250 million mobile
phones globally, hundreds of millions of accessories, in addition to
hundreds of commercial software products.
About NantHealth, Inc.
NantHealth, Inc., a member of the
NantWorks ecosystem of companies, is a next-generation, evidence-based,
personalized healthcare company enabling improved patient outcomes and
more effective treatment decisions for critical illnesses. NantHealth's
unique systems-based approach to personalized healthcare applies novel
diagnostics tailored to the specific molecular profiles of patient
tissues and integrates this molecular data in a clinical setting with
large-scale, real-time biometric signal and phenotypic data to track
patient outcomes and deliver precision medicine. For nearly a decade,
NantHealth has developed an adaptive learning system, which includes its
unique software, middleware and hardware systems infrastructure that
collects, indexes, analyzes and interprets billions of molecular,
clinical, operational and financial data points derived from novel and
traditional sources, continuously improves decision-making and further
optimizes our clinical pathways and decision algorithms over time. For
more information please visit www.nanthealth.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170523005661/en/
Source: NantHealth, Inc.